ロード中...
Changes in Trypanosoma cruzi-specific immune responses following treatment: surrogate markers of treatment efficacy
BACKGROUND: As many as 20 million people are living with Trypanosoma cruzi infection in Latin American, yet few receive any treatment. The major limitation in developing and evaluating potential new drugs for their efficacy is the lack of reliable tests to assess parasite burden and elimination. MET...
保存先:
| 主要な著者: | , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2009
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2805187/ https://ncbi.nlm.nih.gov/pubmed/19877967 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/648072 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|